Rench Wealth Management Inc. trimmed its holdings in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 15.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,262 shares of the semiconductor company’s stock after selling 11,284 shares during the quarter. Lam Research comprises about 7.1% of Rench Wealth Management Inc.’s investment portfolio, making the stock its 2nd biggest holding. Rench Wealth Management Inc.’s holdings in Lam Research were worth $26,113,000 at the end of the most recent quarter.
A number of other large investors also recently bought and sold shares of the business. Fideuram Asset Management Ireland dac purchased a new stake in shares of Lam Research in the 4th quarter worth approximately $10,035,000. Rokos Capital Management LLP increased its position in Lam Research by 42.0% during the 1st quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock valued at $55,532,000 after buying an additional 76,840 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super purchased a new position in Lam Research during the first quarter valued at $59,973,000. Y Intercept Hong Kong Ltd purchased a new position in Lam Research during the first quarter valued at $26,489,000. Finally, Krilogy Financial LLC boosted its holdings in Lam Research by 19.5% in the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after acquiring an additional 4,584 shares in the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently commented on LRCX. UBS Group cut their target price on Lam Research from $435.00 to $425.00 and set a “buy” rating on the stock in a research note on Tuesday, September 1st. TD Cowen reaffirmed a “buy” rating and issued a $400.00 price target (up from $340.00) on shares of Lam Research in a research report on Thursday, July 9th. Morgan Stanley dropped their price target on shares of Lam Research from $404.00 to $367.00 and set an “overweight” rating on the stock in a research note on Thursday, July 30th. Wells Fargo & Company reissued an “overweight” rating and set a $350.00 price objective (down from $450.00) on shares of Lam Research in a research report on Thursday, July 30th. Finally, Stifel Nicolaus raised their price objective on shares of Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a research note on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $361.81.
Insider Buying and Selling
In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the transaction, the director owned 87,142 shares in the company, valued at $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the sale, the insider owned 42,462 shares in the company, valued at $12,843,056.52. This represents a 10.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.31% of the company’s stock.
Lam Research Stock Down 1.4%
Lam Research stock opened at $315.84 on Thursday. Lam Research Corporation has a 12 month low of $104.61 and a 12 month high of $438.50. The stock has a fifty day simple moving average of $315.51 and a two-hundred day simple moving average of $293.41. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The firm has a market cap of $395.22 billion, a price-to-earnings ratio of 54.83, a PEG ratio of 1.27 and a beta of 1.85.
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same period in the prior year, the company posted $1.33 earnings per share. The company’s quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities analysts predict that Lam Research Corporation will post 9.33 EPS for the current fiscal year.
Lam Research Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. This is a boost from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s payout ratio is 18.06%.
Key Stories Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Analyst sentiment remains favorable, with Wall Street maintaining a consensus “Moderate Buy” view. Recent coverage also highlights Lam Research’s exposure to artificial intelligence, high-bandwidth memory and advanced DRAM investment, which could support demand for its semiconductor-manufacturing equipment. Consensus rating article Lam Research momentum article
- Positive Sentiment: Lam’s latest quarterly results exceeded expectations, with earnings per share of $1.82 versus the $1.69 consensus and revenue of $6.72 billion versus $6.66 billion. Revenue increased 30% year over year, and management’s next-quarter earnings guidance points to continued growth. These results underpin the long-term bullish case. Three reasons investors favor Lam Research
- Neutral Sentiment: Lam Research presented at Citi’s 2026 Global TMT Conference. The event could provide additional commentary on customer spending, AI-related demand and industry trends, but the supplied report does not identify a material new forecast or announcement. Citi conference transcript
- Negative Sentiment: The stock’s recent rise—nearly tripling over the past year and gaining about 45% in six months—has left investors vulnerable to profit-taking. With a high earnings multiple, even a normal market pullback or weaker risk appetite can pressure LRCX despite strong operating results. Lam Research larger market drop
- Negative Sentiment: Several articles describe clinical studies involving imaging, MRI or compression therapy. These items appear to be incorrectly associated with Lam Research and do not represent developments in the semiconductor-equipment company; investors should disregard them when assessing LRCX.
Lam Research Profile
Lam Research Corporation is a semiconductor equipment company that develops and manufactures systems used in the fabrication of integrated circuits. Its equipment supports key wafer-processing steps, including deposition, etch, wafer cleaning, and related processes used to create and connect the microscopic features found on semiconductor devices.
The company serves semiconductor manufacturers producing a range of products, including memory, logic, and specialty chips. In addition to manufacturing equipment, Lam Research provides installation, maintenance, spare parts, upgrades, technical support, and other services intended to help customers operate and improve their fabrication facilities.
Founded in 1980, Lam Research is headquartered in Fremont, California, and serves customers through a global network of offices, engineering facilities, and support operations.
Featured Stories
- Five stocks we like better than Lam Research
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
